Disruption of the fibroblast growth factor-2 gene in mice results in decreased bone mass and bone formation
Montero, A.; Okada, Y.; Tomita, M.; Ito, M.; Tsurukami, H.; Nakamura, T.; Doetchmann, T.; Coffin, J.D.; Hurley, M.M.
Journal of Bone and Mineral Research 14(Suppl 1): S161
1999
ISSN/ISBN: 0884-0431 Accession: 034749480
PDF emailed within 1 workday: $29.90
Related References
Montero, A.; Okada, Y.; Tomita, M.; Ito, M.; Tsurukami, H.; Nakamura, T.; Doetschman, T.; Coffin, J.D.; Hurley, M.M. 2000: Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation Journal of Clinical Investigation 105(8): 1085-1093Zhang, X.; Lorenzo, J.; Coffin, D.; Hurley, M.M. 2000: Disruption of the fibroblast growth factor 2 gene in mice results in diminished formation of osteoclasts in bone marrow culture in response to RANKL Journal of Bone and Mineral Research 15(Suppl 1): S155
Brown, T.A.; Gowen, L.C.; Petersen, D.N.; Stock, J.L.; Tkalcevic, G.T.; Vail, A.L.; Simmons, H.A.; Chidsey Frink, K.L.; Ke, H.Z.; Mcneish, J.D. 2000: Targeted disruption of osteoregulin, a novel bone specific gene, results in increased bone formation and bone mass in mice Journal of Bone and Mineral Research 15(Suppl 1): S170
Gowen, L.C.; Petersen, D.N.; Mansolf, A.L.; Qi, H.; Stock, J.L.; Tkalcevic, G.T.; Simmons, H.A.; Crawford, D.T.; Chidsey-Frink, K.L.; Ke, H.Z.; McNeish, J.D.; Brown, T.A. 2003: Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass Journal of Biological Chemistry 278(3): 1998-2007
Geiser, A.G.; Zeng, Q.Q.; Sato, M.; Helvering, L.M.; Hirano, T.; Turner, C.H. 1998: Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-β1 gene Bone (New York) 23(2): 87-93
Geiser, A.G.; Zeng, Q.Q.; Sato, M.; Helvering, L.M.; Hirano, T.; Turner, C.H. 1998: Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene Bone 23(2): 87-93
Lecka-Czernik, B.; Stechschulte, L.A.; Czernik, P.J.; Dowling, A.R. 2015: High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity Molecular and Cellular Endocrinology 410: 35-41
Sakai, A.; Sakata, T.; Tanaka, S.; Okazaki, R.; Kunugita, N.; Norimura, T.; Nakamura, T. 2002: Disruption of the p53 gene results in preserved trabecular bone mass and bone formation after mechanical unloading Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 17(1): 119-127
Nakamura, Y.; Tensho, K.; Nakaya, H.; Nawata, M.; Okabe, T.; Wakitani, S. 2005: Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice Bone 36(3): 399-407
Lane, N.E.; Kumer, J.; Kahn, M.; Wronski, T.; Kinney, J. 2000: Can basic fibroblast growth factor increase bone mass in osteopenic ovariectomized rats? Preliminary results of bone turnover markers Journal of Bone and Mineral Research 15(Suppl 1): S427
Nakamura, Y.kio; Tensho, Keiji; Nakaya, Hiroyuki; Nawata, Masashi; Okabe, Takahiro; Wakitani, Shigeyuki 2007: Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice (vol 36, pg 399, 2005) Bone (New York) 40(1): 244-245
Yu, H.; Wergedal, J.E.; Zhao, Y.; Mohan, S. 2012: Targeted disruption of TGFBi in mice reveals its role in regulating bone mass and bone size through periosteal bone formation Calcified Tissue International 91(1): 81-87
Okuma, K.Furukawa.; Menuki, K.; Tsukamoto, M.; Tajima, T.; Fukuda, H.; Okada, Y.; Mori, T.; Tsuchiya, T.; Kawamoto, T.; Yoshida, Y.; Uchida, S.; Sakai, A. 2017: Disruption of the Aldehyde Dehydrogenase 2 Gene Results in No Increase in Trabecular Bone Mass Due to Skeletal Loading in Association with Impaired Cell Cycle Regulation Through p21 Expression in the Bone Marrow Cells of Mice Calcified Tissue International 101(3): 328-340
Hurley, M.M.; Sobue, T.; Zhang, X. 2001: Short term fibroblast growth factor-2 treatment increases osteoblast differentiation and bone nodule formation, in bone marrow cultures from young and adult mice Journal of Bone and Mineral Research 16(Suppl 1): S250
Sasaki, S.; Tsukamoto, M.; Saito, M.; Hojyo, S.; Fukada, T.; Takami, M.; Furuichi, T. 2018: Disruption of the mouse Slc39a14 gene encoding zinc transporter ZIP14 is associated with decreased bone mass, likely caused by enhanced bone resorption Febs Open Bio 8(4): 655-663
Wang, L.; Zhang, Y.; You, S.; Tan, L.; Huang, Y. 2012: Response of bone morphogenetic protein-2 and basic fibroblast growth factor in bone marrow stromal cells in ectopic and in situ bone formation Hua Xi Kou Qiang Yi Xue Za Zhi 30(4): 420-424
Kuhn, L.T.; Ou, G.; Charles, L.; Hurley, M.M.; Rodner, C.M.; Gronowicz, G. 2013: Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone Journals of Gerontology. Series a Biological Sciences and Medical Sciences 68(10): 1170-1180
Wang, W.; Li, S.; Niu, D.; Liu, F.; Sun, J.; Zhang, Z. 2011: Relationship between the bone mass and the expressions of vascular endothelial growth factor, basic fibroblast growth factor, and bone morphogenetic protein 2 mRNA in avascular necrosis of femoral head Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 25(8): 984-991
Mostafa, Y.A.; Meyer, R.A.Jr 1981: Increased bone formation and decreased bone resorption in young x linked hypo phosphatemic mice the cause for the transitory increased metaphyseal bone mass Calcified Tissue International 33(3): 310
Larsen, M.; Willems, W.F.; Pelzer, M.; Friedrich, P.F.; Dadsetan, M.; Bishop, A.T. 2014: Fibroblast growth factor-2 and vascular endothelial growth factor mediated augmentation of angiogenesis and bone formation in vascularized bone allotransplants Microsurgery 34(4): 301-307